Javascript must be enabled to continue!
SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
View through CrossRef
Abstract
BackgroundSero-prevalence studies quantify the proportion of a population that has antibodies against SARS-CoV-2, and can be used to identify the extent of the COVID-19 pandemic at a population level. The aim of the study was to assess the sero-prevalence of SARS-CoV-2 antibodies in the workforce at three workplaces. Methods993 participants were recruited from three workplaces in South Wales: a food factory, a non-food factory and a call centre. Participants completed a questionnaire and received lateral flow point-of-care SARS-CoV-2 antibody tests. The data were analysed using multivariable logistic regression, both using complete records only and following multiple imputation. ResultsThe sero-prevalence of SARS-CoV-2 antibodies ranged from 4% (n=17/402) in the non-food factory to 10% (n=28/281) in the food factory (OR 2.93; 95% CI 1.26 to 6.81). After taking account of confounding factors evidence of a difference remained (cOR comparing food factory to call centre (2.93; 95% CI 1.26 to 6.81) and non-food factory (3.99; 95% CI 1.97 to 8.08) respectively). The SARS-CoV-2 antibody prevalence also varied between roles within workplaces. People working in office based roles had a 2.23 times greater conditional odds (95% CI 1.02 to 4.87) of being positive for SARS-CoV-2 antibodies than those working on the factory floor.ConclusionThe sero-prevalence of SARS-CoV-2 antibodies varied by workplace and work role. Whilst it is not possible to state whether these differences are due to COVID-19 transmission within the workplaces, it highlights the importance of considering COVID-19 transmission in a range of workplaces and work roles.
Research Square Platform LLC
Title: SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
Description:
Abstract
BackgroundSero-prevalence studies quantify the proportion of a population that has antibodies against SARS-CoV-2, and can be used to identify the extent of the COVID-19 pandemic at a population level.
The aim of the study was to assess the sero-prevalence of SARS-CoV-2 antibodies in the workforce at three workplaces.
Methods993 participants were recruited from three workplaces in South Wales: a food factory, a non-food factory and a call centre.
Participants completed a questionnaire and received lateral flow point-of-care SARS-CoV-2 antibody tests.
The data were analysed using multivariable logistic regression, both using complete records only and following multiple imputation.
ResultsThe sero-prevalence of SARS-CoV-2 antibodies ranged from 4% (n=17/402) in the non-food factory to 10% (n=28/281) in the food factory (OR 2.
93; 95% CI 1.
26 to 6.
81).
After taking account of confounding factors evidence of a difference remained (cOR comparing food factory to call centre (2.
93; 95% CI 1.
26 to 6.
81) and non-food factory (3.
99; 95% CI 1.
97 to 8.
08) respectively).
The SARS-CoV-2 antibody prevalence also varied between roles within workplaces.
People working in office based roles had a 2.
23 times greater conditional odds (95% CI 1.
02 to 4.
87) of being positive for SARS-CoV-2 antibodies than those working on the factory floor.
ConclusionThe sero-prevalence of SARS-CoV-2 antibodies varied by workplace and work role.
Whilst it is not possible to state whether these differences are due to COVID-19 transmission within the workplaces, it highlights the importance of considering COVID-19 transmission in a range of workplaces and work roles.
Related Results
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Abstract
Background
SARS-CoV-2 serology tests are clinically useful to document a prior SARS-CoV-2 infection in patients with n...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found
on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus
genome is the bi...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Coronavirus infections in monocytes and macrophages
Coronavirus infections in monocytes and macrophages
Severe cases of SARS-CoV-2, the causative agent of COVID-19, are often accompanied by dysregulated immune responses. Monocytes and Macrophages, which are part of the innate immune ...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
P-003 Impact of SARS-CoV-2 infection on circulating male sex hormones and human semen quality: a systematic review and meta-analysis
P-003 Impact of SARS-CoV-2 infection on circulating male sex hormones and human semen quality: a systematic review and meta-analysis
Abstract
Study question
Does SARS-CoV-2 infection alter human male sex steroid hormones and semen quality?
...

